Close Menu

cancer subtypes

Signifikance's platform is currently used for analyzing and interpreting cancer variants but will soon support prenatal screening and testing as well.

The firm will launch an onsite version of its clinical decision support system this year and expects to add tumor profiling services next year.

Researchers did genome sequencing and copy number testing on samples from 100 pancreatic ductal carcinoma patients, building on prior ICGC exome findings.

NEW YORK (GenomeWeb) — Data from the Neoadjuvant Breast Registry Symphony Trial, led by Pat Whitworth of the Nashville Breast Center and funded by Agendia, have confirmed earlier findings supporting Agendia's BluePrint molecular subtyping assay as a more effective predictor of adjuvant chemothera

NEW YORK (GenomeWeb) — An analysis of data from The Cancer Genome Atlas' comprehensive molecular profiling of squamous cell head and neck cancer has revealed a more complicated molecular landscape for the disease, and has identified a new genomic subset that indicates particularly poor survival.

NEW YORK (GenomeWeb) — A study of RNA-seq data from several Cancer Genome Atlas cohorts has found that patterns of pseudogene expression correspond strongly with several molecularly or clinically defined cancer subtypes and, in some cases, might offer additional subtyping or prognostic prediction

Researchers from the Dana Farber Cancer Institute have published results of a preliminary study tracking the patterns of mutations in the two histological subtypes of cervical cancer, which they are now planning to put to the test in a clinical trial of PI3 kinase inhibitors.

Researchers collaborating among a number of French institutions have developed and validated a novel gene-expression signature that classifies colon cancers into six distinct molecular subtypes with different pathological characteristics and varying prognoses.

Results from The Cancer Genome Atlas' analysis of several hundred endometrial cancers have classified the disease into four molecularly defined groups with differing prognoses.

Rosetta Genomics has published a study describing the development and initial validation of its miRview Kidney test, a 24-microRNA array-based assay that classifies a patient's primary kidney tumor into one of four main subtypes.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.